Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(14)
MIXED(1)
exatecan mesylate
13 trials
phase_1phase_2phase_3
daiichi-sankyo
gemcitabine hydrochloride
1 trial
phase_3
daiichi-sankyo
filgrastim
1 trial
phase_1
daiichi-sankyo
3 unique interventions2 categories

Analytics

Trial Phases

Phase 12
Phase 210
Phase 31

Trial Status

Completed13

Role Distribution

Other Roles13

Activity Timeline

Clinical Trials (13)

NCT00003951Phase 2Completed
DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
Pancreatic Cancer
Studychair
NCT00004045Phase 2Completed
Chemotherapy in Treating Patients With Prostate Cancer
Prostate Cancer
Studychair
NCT00004046Phase 2Completed
Chemotherapy in Treating Women With Metastatic Breast Cancer
Breast Cancer
Studychair
NCT00004047Phase 1Completed
Chemotherapy in Treating Patients Who Have Hematologic Cancer
LeukemiaMyelodysplastic Syndromes
Studychair
NCT00004060Phase 2Completed
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Studychair
NCT00004108Phase 2Completed
DX-8951f in Treating Patients With Liver Cancer
Liver Cancer
Studychair
NCT00004212Phase 1Completed
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Studychair
NCT00004866Phase 2Completed
DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
Cervical Cancer
Studychair
NCT00005938Phase 2Completed
DX-8951f in Treating Patients With Biliary Cancer
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Studychair
NCT00017212Phase 2Completed
DX-8951f in Treating Patients With Metastatic Stomach Cancer
Esophageal CancerGastric Cancer
Studychair

Showing 10 of 13 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverCancer of PancreasBreast Cancer+5 more
Similarity Score13%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerOvary CancerCancer of Pancreas+2 more
Similarity Score8%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerProstate CancerCancer of Esophagus+2 more
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast CancerCancer of LiverCancer of Pancreas+1 more
Similarity Score7%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Cancer of EsophagusCancer of StomachProstate Cancer+1 more
Similarity Score7%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of StomachCancer of PancreasBreast Cancer+1 more
Similarity Score7%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cancer of LiverCancer of PancreasBreast Cancer
Similarity Score5%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

LymphomaOvary CancerCancer of Pancreas
Similarity Score5%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLymphoma
Similarity Score5%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Ovary CancerCancer of the Uterine CervixCancer of Pancreas
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT00003951Phase 2StudyChair

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Pancreatic Cancer
Completed
NCT00004045Phase 2StudyChair

Chemotherapy in Treating Patients With Prostate Cancer

Prostate Cancer
Completed
NCT00004046Phase 2StudyChair

Chemotherapy in Treating Women With Metastatic Breast Cancer

Breast Cancer
Completed
NCT00004047Phase 1StudyChair

Chemotherapy in Treating Patients Who Have Hematologic Cancer

LeukemiaMyelodysplastic Syndromes
Completed
NCT00004060Phase 2StudyChair

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Completed
NCT00004108Phase 2StudyChair

DX-8951f in Treating Patients With Liver Cancer

Liver Cancer
Completed
NCT00004212Phase 1StudyChair

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Completed
NCT00004866Phase 2StudyChair

DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

Cervical Cancer
Completed
NCT00005938Phase 2StudyChair

DX-8951f in Treating Patients With Biliary Cancer

Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Completed
NCT00017212Phase 2StudyChair

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Esophageal CancerGastric Cancer
Completed
NCT00023972Phase 3StudyChair

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer
Completed
NCT00055939Phase 2StudyChair

Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma

Sarcoma
Completed
NCT00055952Phase 2StudyChair

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Sarcoma
Completed

All 13 trials loaded